With reference to the above captioned subject, we wish to inform you that the Board of Directors at their meeting held on Thursday, November 13, 2025 approved the following: 1). Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Centenial Surgical Suture Ltd announced that its Board of Directors, at a meeting held on November 13, 2025 (6:00 PM to 6:25 PM), approved three items: (1) Standalone Un-Audited Financial Results for the quarter and half year ended September 30, 2025, (2) Statement of Assets and Liabilities for the half year ended September 30, 2025, and (3) Cash Flow Statement for the half year ended September 30, 2025. The filing was made under SEBI LODR Regulation 30 and 33. No specific financial figures have been disclosed in this filing — it is purely an intimation of board approval of the results documents.
This is a routine compliance filing confirming the board's approval of Q2/H1 FY26 results. The actual financial numbers are not shared in this intimation and would have been filed separately; investors should look at the detailed results document to assess performance. No material strategic or structural change is indicated.